|1.||Adlercreutz, Herman: 15 articles (05/2009 - 03/2002)|
|2.||Linseisen, Jakob: 8 articles (08/2014 - 06/2004)|
|3.||Saarinen, Niina M: 8 articles (08/2010 - 08/2002)|
|4.||Chang-Claude, Jenny: 7 articles (08/2014 - 06/2004)|
|5.||Adlercreutz, H: 7 articles (08/2008 - 03/2001)|
|6.||Thompson, Lilian U: 7 articles (07/2007 - 07/2003)|
|7.||Kaaks, Rudolf: 5 articles (08/2014 - 12/2004)|
|8.||Tjønneland, Anne: 5 articles (06/2013 - 10/2004)|
|9.||Olsen, Anja: 5 articles (06/2013 - 10/2004)|
|10.||Overvad, Kim: 5 articles (06/2013 - 10/2004)|
|1.||Breast Neoplasms (Breast Cancer)
04/01/2012 - "We previously demonstrated that high serum enterolactone levels are associated with a reduced incidence of breast cancer in healthy women. "
06/01/2013 - "To prospectively examine this association, we measured plasma enterolactone levels in 802 breast cancer cases and 802 matched controls nested among predominantly premenopausal women in the Nurses' Health Study II cohort. "
06/01/2013 - "Plasma enterolactone and breast cancer risk in the Nurses' Health Study II."
04/01/2012 - "The present study was aimed at investigating whether a similar association might be found between serum enterolactone levels and the mortality of women with early breast cancer. "
03/15/2012 - "The overall evidence together with other studies supports an inverse association between higher serum enterolactone levels and postmenopausal breast cancer risk."
|2.||Prostatic Neoplasms (Prostate Cancer)
05/01/2002 - "No support for the hypothesis that high circulating enterolactone is protective against prostate cancer was found."
02/01/2013 - "There is evidence that a mammalian lignan, enterolactone (ENL), decreases the proliferation rate of prostate cancer cells, although previous studies have used concentrations difficult to achieve through dietary modification. "
04/01/2009 - "The finding of this study provides new insights into the molecular mechanisms that enterolactone exerts against prostate cancer."
04/01/2009 - "This study examined whether the growth inhibitory effect of enterolactone was related to changes in the IGF-1/IGF-1R system in PC-3 prostate cancer cells. "
09/01/2007 - "Our findings encourage further studies of enterolactone as a promising chemopreventive agent against prostate cancer."
12/18/1999 - "The lignan enterolactone, produced by the intestinal microflora from dietary precursors, has been implicated in protection against cancer. "
08/01/2008 - "Although the estimated ICC for blood samples was moderate, it indicates that enterolactone levels of both fasting and non-fasting blood samples should be useful in future projects within the Malmö Diet and Cancer cohort."
08/01/2008 - "Variation in fasting and non-fasting serum enterolactone concentrations in women of the Malmö Diet and Cancer cohort."
05/12/2003 - "Enterolactone is a plant-derived compound that has been associated with a reduced risk of acute coronary events and cancer. "
08/01/2002 - "Both intake of whole grain and higher levels of serum enterolactone have been related to reduced risk for CHD and some cancers. "
|4.||Colonic Neoplasms (Colon Cancer)
05/01/2005 - "Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo."
01/01/2010 - "In conclusion, with higher enterolactone levels, we found lower risk of colon cancer among women and higher risk of rectal cancer among men."
11/01/2010 - "Our previous study demonstrated that lignan metabolites enterolactone and enterodiol inhibited colonic cancer cell growth by inducing cell cycle arrest and apoptosis. "
01/01/2010 - "Among men, a doubling in enterolactone tended to be associated with higher risk of colon cancer [IRR (95% CI) = 1.09 (0.89-1.34)] and was associated with statistically significantly higher risk of rectal cancer [IRR (95% CI) = 1.74 (1.25-2.44)]. "
01/01/2010 - "For each doubling in enterolactone concentration, we found lower risk of colon cancer among women [IRR (95% CI) = 0.76 (0.60-0.96)] and a tendency toward lower risk of rectal cancer [IRR (95% CI) = 0.83 (0.60-1.14)]. "
09/01/2007 - "Enterolactone has been suggested to be the prime active compound mediating atherosclerosis-protective effects that were shown for flaxseed. "
09/01/2007 - "In conclusion, the blood mononuclear cell proteome responds to dietary flaxseed intake with changes in a number of atherosclerosis-relevant proteins that may be taken as biomarkers of exposure and some of these changes observed can be attributed to the action of the lignan metabolite enterolactone."
|1.||Vegetarian Diet (Vegetarianism)